All sponsors

LEO Pharma

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING4
READOUTS ≤12 MONTHS2
Open LEO Pharma on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
TRAPEDS 2
NCT06311682
P3RecruitingAtopic Dermatitis1952026-10-16 (+7 mo)
Delgocitinib cream
NCT07013201
P2RecruitingPalmoplantar Pustulosis1352027-06-04 (+6 mo)
Spesolimab
NCT03886246
P2Active, not recruitingGeneralized Pustular Psoriasis1312027-09-30 (+20 mo)
Spesolimab
NCT06624670
P3RecruitingPyoderma Gangrenosum902027-11-12 (+10 mo)
DELTA CARE 1
NCT07335588
P3RecruitingLichen Sclerosus5522028-03-10